Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichiro Kataoka

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|September 8, 2004
Differential cooperation between dHAND and three different E-proteinsMasao Murakami, Keiichiro Kataoka, Junji Tominaga, et al.
European Journal of Biochemistry|August 5, 2004
Akt-dependent phosphorylation negatively regulates the transcriptional activity of dHAND by inhibiting the DNA binding activityMasao Murakami, Keiichiro Kataoka, Shigetomo Fukuhara, et al.
Biochemical and Biophysical Research Communications|October 30, 2007
Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysisYoshiko Tokutomi, Norie Araki, Keiichiro Kataoka, et al.
Circulation|November 4, 2005
Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesisKoichi Nishiyama, Kentaro Takaji, Keiichiro Kataoka, et al.
Journal of Hypertension|October 30, 2009
Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese miceMasaya Fukuda, Taishi Nakamura, Keiichiro Kataoka, et al.
Journal of Hypertension|March 13, 2010
Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive ratsEiichiro Yamamoto, Keiichiro Kataoka, Yi-Fei Dong, et al.
Hypertension (Dallas, Tex. : 1979)|August 22, 2007
Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive ratEiichiro Yamamoto, Keiichiro Kataoka, Takuro Yamashita, et al.
Journal of Hypertension|September 8, 2006
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosisEiichiro Yamamoto, Zhong-Fang Lai, Takuro Yamashita, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2007
Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartanTaishi Nakamura, Eiichiro Yamamoto, Keiichiro Kataoka, et al.
Journal of Hypertension|October 12, 2010
Apoptosis signal-regulating kinase 1 deficiency eliminates cardiovascular injuries induced by high-salt dietKeiichiro Kataoka, Yoshiko Tokutomi, Eiichiro Yamamoto, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|September 8, 2004
Differential cooperation between dHAND and three different E-proteinsMasao Murakami, Keiichiro Kataoka, Junji Tominaga, et al.
European Journal of Biochemistry|August 5, 2004
Akt-dependent phosphorylation negatively regulates the transcriptional activity of dHAND by inhibiting the DNA binding activityMasao Murakami, Keiichiro Kataoka, Shigetomo Fukuhara, et al.
Biochemical and Biophysical Research Communications|October 30, 2007
Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysisYoshiko Tokutomi, Norie Araki, Keiichiro Kataoka, et al.
Circulation|November 4, 2005
Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesisKoichi Nishiyama, Kentaro Takaji, Keiichiro Kataoka, et al.
Journal of Hypertension|October 30, 2009
Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese miceMasaya Fukuda, Taishi Nakamura, Keiichiro Kataoka, et al.
Journal of Hypertension|March 13, 2010
Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive ratsEiichiro Yamamoto, Keiichiro Kataoka, Yi-Fei Dong, et al.
Hypertension (Dallas, Tex. : 1979)|August 22, 2007
Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive ratEiichiro Yamamoto, Keiichiro Kataoka, Takuro Yamashita, et al.
Journal of Hypertension|September 8, 2006
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosisEiichiro Yamamoto, Zhong-Fang Lai, Takuro Yamashita, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2007
Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartanTaishi Nakamura, Eiichiro Yamamoto, Keiichiro Kataoka, et al.
Journal of Hypertension|October 12, 2010
Apoptosis signal-regulating kinase 1 deficiency eliminates cardiovascular injuries induced by high-salt dietKeiichiro Kataoka, Yoshiko Tokutomi, Eiichiro Yamamoto, et al.
Pageof 5